Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polymyxin E administration route and renal function in severe XDR-GNB pulmonary infection
ChiCTR2100052127Phase 4Not yet recruiting
- Sponsor
- Xinyang Central Hospital
- Start
- Jan 2022
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of colistin (2 arms), sponsored by Xinyang Central Hospital. Primary endpoints: Serum creatinine level, Serum urea nitrogen level and 2 more. Planned start Jan 2022; status: not yet recruiting.
02
Drugs
colistin
Beyond the preview
Go deeper on ChiCTR2100052127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100052127.